LLY vs RMD
By Alex · Tickerpine
Eli Lilly and Company vs ResMed Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | RMD |
|---|---|---|
| Price | $1,208.12 | $200.29 |
| Market cap | $1.08T | $29.05B |
| P/E ratio | 42.9 | 19.3 |
| ROE | 107.46% | 25.25% |
| Profit margin | 34.99% | 27.44% |
| Revenue growth | 55.50% | 10.80% |
| Dividend yield | 0.57% | 1.20% |
| Beta | 0.52 | 0.78 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs RMD in plain English
- LLY is the bigger company — about 37.1× the market cap of RMD.
- RMD is cheaper on earnings (P/E 19.3 vs 42.9).
- LLY earns a higher return on equity (107% vs 25%).
- LLY is growing revenue faster (56% vs 11%).
- RMD has the higher dividend yield (1.20% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
RMD return calculator
See what $1,000 in ResMed Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.